Get started Log in

MODTX — Modus Therapeutics Holding AB Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
SEK27.44m
Enterprise Value
SEK14.95m
Revenue

Brief: Modus Therapeutics Announces First Patient Enrolled In Phase I Sevusmart Clinical Trial Evaluating Sevuparin In Paediatric Patients With Severe Malaria
01/09/2022 21:26
Brief: Modus Q2 Loss After Tax At SEK 3.0 Mln
23/08/2022 07:14
Brief: Modus Therapeutics Updates On Sevuparin Phase 1B Clinical Trial Timelines
25/05/2022 17:01
Brief: Modus Q1 Loss After Tax Widens To SEK 3.1 Million
16/05/2022 07:35
Brief: Modus Therapeutics Secures Bridge Financing
12/05/2022 15:34
Brief: Modus Therapeutics Q4 Loss After Tax Widens To SEK 12.3 Mln
22/02/2022 07:10
Brief: Modus Therapeutics Q3 Loss After Tax Widens To SEK 4.4 Mln
18/11/2021 07:16